This is the third FDA approval for Omvoh this year, following approvals for Crohn's disease and a citrate-free formulation INDIANAPOLIS, Oct. 27, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) ...
Epinephrine Injection in a 30 mg per 30 mL Multi-Dose Vial is now available from Fresenius Kabi, expanding the company’s offerings of Epinephrine Injection. In December 2024, Fresenius Kabi introduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback